| 摘要 |
PURPOSE: A pharmaceutical composition or food composition containing mixed lactic acid bacteria is provided to enhance the number of total lactic acid bacteria in intestine and to promote adipose decomposition. CONSTITUTION: A pharmaceutical composition for treating or preventing obesity or obesity-associated diseases contains mixed lactic acid bacteria as an active ingredient. The mixed lactic acid bacteria contain Bipidobacterium pseudocatenulatum SPM 1204 (deposit number KCTC 10616BP), Bifidobacterium longum SPM 1205(deposit number KCTC 10630BP), and Bifidobacterium longum SPM 1207(deposit number KCTC 11506 BP). |
